Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia. | Leukemia | 2022 | 35523865 | PubTator, text mining | PubMed |
| Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific manners. | JCI Insight | 2022 | 35511436 | PubTator, text mining | PubMed |
| Concurrent B Cell Acute Lymphoblastic Lymphoma/Leukemia and Monoclonal B Cell Lymphocytosis: A Case Report with Extensive Molecular Analysis. | Case Rep Hematol | 2022 | 35495178 | PubTator, text mining | PubMed |
| Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite. | Structure | 2022 | 35489332 | PubTator, text mining | PubMed |
| RNA-seq profiling of tubulointerstitial tissue reveals a potential therapeutic role of dual anti-phosphatase 1 in glomerulonephritis. | J Cell Mol Med | 2022 | 35488446 | PubTator, text mining | PubMed |
| Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy. | Blood Adv | 2022 | 35486482 | PubTator, text mining | PubMed |
| An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer. | J Clin Invest | 2022 | 35472136 | PubTator, text mining | PubMed |
| Identification of a Cancer-Predisposing Germline POT1 p.Ile49Metfs*7 Variant by Targeted Sequencing of a Splenic Marginal Zone Lymphoma. | Genes (Basel) | 2022 | 35456397 | PubTator, text mining | PubMed |
| Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence. | J Clin Med | 2022 | 35456167 | PubTator, text mining | PubMed |
| Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients. | Curr Oncol | 2022 | 35448201 | PubTator, text mining | PubMed |
| A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation. | Nat Commun | 2022 | 35440565 | PubTator, text mining | PubMed |
| Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022. | Memo | 2022 | 35437451 | PubTator, text mining | PubMed |
| [72/m with an incidental finding of lymphocytosis]. | Onkologe (Berl) | 2022 | 35431461 | PubTator, text mining | PubMed |
| Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. | Leuk Res | 2022 | 35430388 | PubTator, text mining | PubMed |
| Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial. | Blood | 2022 | 35427411 | PubTator, text mining | PubMed |
| A case of bone lesion in a patient with relapsed chronic lymphocytic leukemia and review of the literature. | Clin Case Rep | 2022 | 35414919 | PubTator, text mining | PubMed |
| Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2. | Int J Mol Sci | 2022 | 35408790 | PubTator, text mining | PubMed |
| Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis. | J Clin Med | 2022 | 35407474 | PubTator, text mining | PubMed |
| TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression. | Cancers (Basel) | 2022 | 35406446 | PubTator, text mining | PubMed |
| Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations. | Hemasphere | 2022 | 35392482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=32